Preparation and Analysis of Rosa damascena Essential Oil Composition and Antimicrobial Activity Assessment of Related Fractions

[1]  Mohd Ali,et al.  Volatile oil composition of Rosa damascena Mill. (Rosaceae) , 2014 .

[2]  S. Emami,et al.  Inhibitory effect of Rosa damascena Mill flower essential oil, geraniol and citronellol on rat ileum contraction , 2013, Research in pharmaceutical sciences.

[3]  K. Karakuş,et al.  Rose oil (from Rosa × damascena Mill.) vapor attenuates depression-induced oxidative toxicity in rat brain , 2012, Journal of Natural Medicines.

[4]  T. Efferth,et al.  Activities of ten essential oils towards Propionibacterium acnes and PC-3, A-549 and MCF-7 cancer cells. , 2010, Molecules.

[5]  M. Emaneini,et al.  Antimicrobial effect of Rosa damascena extract on selected endodontic pathogens. , 2010, Journal - California Dental Association.

[6]  Moein Mahmoodreza,et al.  COMPOSITION OF THE ESSENTIAL OIL OF ROSA DAMASCENA MILL. FROM SOUTH OF IRAN , 2010 .

[7]  A. Hadjiakhoondi,et al.  Chemical Composition and Antioxidant Activity of the Extract and Essential oil of Rosa damascena from Iran, Population of Guilan , 2009 .

[8]  G. Adwan,et al.  Synergistic Effects of Plant Extracts and Antibiotics on Staphylococcus aureus Strains Isolated from Clinical Specimens , 2009 .

[9]  A. Nikbakht,et al.  A STUDY ON THE RELATIONSHIPS BETWEEN IRANIAN PEOPLE AND DAMASK ROSE (ROSA DAMASCENA) AND ITS THERAPEUTIC AND HEALING PROPERTIES , 2008 .

[10]  M. Prenna,et al.  Analysis of meticillin-susceptible and meticillin-resistant biofilm-forming Staphylococcus aureus from catheter infections isolated in a large Italian hospital. , 2008, Journal of medical microbiology.

[11]  C. Bantar,et al.  Impact of Antibiotic Treatment on Bacterial Resistance Rates from Patients with Hospital-Acquired Infection , 2007, Journal of chemotherapy.

[12]  R. Chemaly,et al.  Outcomes for and Risk Factors Associated With Vancomycin-Resistant Enterococcus faecalis and Vancomycin-Resistant Enterococcus faecium Bacteremia in Cancer Patients , 2007, Infection Control & Hospital Epidemiology.

[13]  Rajendra Prasad,et al.  Pathogenicity and drug resistance in Candida albicans and other yeast species. A review. , 2007, Acta microbiologica et immunologica Hungarica.

[14]  H. Loghmani-Khouzani.  Essential Oil Composition of Rosa damascena Mill Cultivated in Central Iran , 2007 .

[15]  R. P. Adams.  Identification of Essential Oil Components By Gas Chromatography/Mass Spectrometry , 2007 .

[16]  M. Ghasemzadeh,et al.  Comparative hypnotic effect of Rosa damascena fractions and Diazepam in Mice. , 2007 .

[17]  T. Kirikae,et al.  Molecular epidemiology of outbreaks and containment of drug-resistant Pseudomonas aeruginosa in a Tokyo hospital , 2007, Journal of Infection and Chemotherapy.

[18]  N. Sekeroglu,et al.  Seasonal and diurnal variability of essential oil and its components in Origanum onites L. grown in the ecological conditions of Çukurova , 2005 .

[19]  Jaymand Kamkar,et al.  COMPARATIVE STUDY OF ESSENTIAL OILS OF ROSA DAMASCENA MILL. FROM ISFAHAN PROVINCE , 2005 .

[20]  S. Shin,et al.  Antifungal effects of herbal essential oils alone and in combination with ketoconazole against Trichophyton spp. , 2004, Journal of applied microbiology.

[21]  Osman Sagdic,et al.  Note: Antioxidant and Antibacterial Activities of Rosa Damascena Flower Extracts , 2004 .

[22]  S. Burt,et al.  Essential oils: their antibacterial properties and potential applications in foods--a review. , 2004, International journal of food microbiology.

[23]  H. Baydar,et al.  The effects of harvest date, fermentation duration and Tween 20 treatment on essential oil content and composition of industrial oil rose (Rosa damascena Mill.) , 2004 .

[24]  National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. , 2004, American journal of infection control.

[25]  R. Tauxe.  Emerging foodborne pathogens. , 2002, International journal of food microbiology.

[26]  Nnis System,et al.  National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1990-May 1999, issued June 1999. A report from the NNIS System. , 1999, American journal of infection control.

[27]  R. Gaynes,et al.  Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. , 1999, Critical care medicine.

[28]  J. Vallés,et al.  Nosocomial bacteremia in critically ill patients: a multicenter study evaluating epidemiology and prognosis. Spanish Collaborative Group for Infections in Intensive Care Units of Sociedad Espanola de Medicina Intensiva y Unidades Coronarias (SEMIUC). , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[29]  R. Gaynes,et al.  Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[30]  T. Riley,et al.  Broth micro-dilution method for determining the susceptibility of Escherichia coli and Staphylococcus aureus to the essential oil of Melaleuca alternifolia (tea tree oil). , 1995, Microbios.

[31]  A. Bayrak,et al.  Volatile oil composition of Turkish rose (Rosa damascena) , 1994 .

[32]  E. Anaissie,et al.  Antifungal susceptibility of 44 clinical isolates of Fusarium species determined by using a broth microdilution method , 1989, Antimicrobial Agents and Chemotherapy.